ISPOR Europe 2023

Healthcare policies are rapidly changing to address real-world evidence (RWE), international collaboration, affordability, and fairness.

ISPOR Europe 2023 will focus on the role of health economics and outcomes research (HEOR) in shaping these policies. RWE is crucial for improving data quality, causal inference, and privacy protection in regulatory and payer decisions. International collaboration enhances outcome measurement and evidence transferability for health technology assessment (HTA). Balancing affordability, equity, and innovation necessitates precise measurement of healthcare benefits and costs.

RPN will be joining global healthcare leaders at ISPOR Europe 2023 in Copenhagen from November 12-15 for expert-led sessions on these topics and more.

RPN aims to network with peers, HEOR experts, and thought leaders to discuss sustainable value for health systems, patients, and technology developers.

Let’s meet: reach out to our Business Development Team at bd@regulatorypharmanet.com

Comments are closed for this post.